Dr Natalie Steck, International HTA Strategy & Policy Lead, MSD (a subsidiary of Merck & Co., Inc., Kenilworth, USA), Switzerland

Dr. Natalie Steck is a biomedical researcher by training with more than 10 years’ experience in market access within the pharmaceutical industry. She is committed to building collaborative networks that accelerate broad, sustainable patient access to new innovations. Her team focuses on supporting the successful implementation of EU HTA and embedding relevant considerations into product development.